PDF(1020 KB)
PDF(1020 KB)
PDF(1020 KB)
新生儿毛细血管渗漏综合征
Neonatal capillary leak syndrome
新生儿毛细血管渗漏综合征是一种有明确病因或诱因，以低血压、血液浓缩、低蛋白血症和全身水肿为主要表现的临床综合征，病情危重，容易发生多器官功能衰竭，甚至死亡。但对其诊断及治疗仍存在很大争议。该文对近年来新生儿毛细血管渗漏综合征的诊断与治疗进展进行总结，以期提高临床医生对该病的诊治水平。
Neonatal capillary leak syndrome is a clinical syndrome with definite etiology or predisposing factors and has the manifestations of hypotension, hemoconcentration, hypoproteinemia, and systemic edema. This disease often has critical conditions and may lead to multiple organ failure and even death. There are still controversies over the diagnosis and treatment of this disease. This article summarizes the recent advances in the diagnosis and treatment of neonatal capillary leak syndrome, in order to improve the diagnosis and treatment of this disease among clinicians.
[1] Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome:etiologies, pathophysiology, and management[J]. Kidney Int, 2017, 92(1):37-46.
[2] Moynihan GV, Teo PC, Lee FJ, et al. Capillary leak syndrome with tamponade[J]. Anaesth Intensive Care, 2019, 47(3):305-306.
[3] Kerling A, Toka O, Rüffer A, et al. First experience with tolvaptan for the treatment of neonates and infants with capillary leak syndrome after cardiac surgery[J]. BMC Pediatr, 2019, 19(1):57.
[4] Kubicki R, Grohmann J, Siepe M, et al. Early prediction of capillary leak syndrome in infants after cardiopulmonary bypass[J]. Eur J Cardiothorac Surg, 2013, 44(2):275-281.
[5] Esper SA, Subramaniam K, Tanaka KA. Pathophysiology of cardiopulmonary bypass:current strategies for the prevention and treatment of anemia, coagulopathy, and organ dysfunction[J]. Semin Cardiothorac Vasc Anesth, 2014, 18(2):161-176.
[6] Darvishi B, Farahmand L, Jalili N, et al. Probable mechanisms involved in immunotoxin mediated capillary leak syndrome (CLS) and recently developed countering strategies[J]. Curr Mol Med, 2018, 18(5):335-342.
[7] Ramirez-Sandoval JC, Varela-Jimenez R, Morales-Buenrostro LE. Capillary leak syndrome as a complication of antibody-mediated rejection treatment:a case report[J]. CEN Case Rep, 2018, 7(1):110-113.
[8] Miyamoto T, Ozaki S, Inui A, et al. C1 esterase inhibitor in pediatric cardiac surgery with cardiopulmonary bypass plays a vital role in activation of the complement system[J]. Heart Vessels, 2020, 35(1):46-51.
[9] Siddall E, Radhakrishnan J. Capillary leak syndrome:a cytokine and catecholamine storm?[J]. Kidney Int, 2019, 95(5):1009-1011.
[10] Raith EP, Ihle JF, Jamieson J, et al. Idiopathic systemic capillary leak syndrome presenting as septic shock:a case report[J]. Heart Lung, 2018, 47(4):425-428.
[11] 代冬梅, 唐坤, 许汪斌, 等. 系统性毛细血管渗漏综合征病程中血细胞比容与血浆白蛋白差值的变化:系统评价分析[J]. 中华危重病急救医学, 2018, 30(10):920-924.
[12] Baloch NU, Bikak M, Rehman A, et al. Recognition and management of idiopathic systemic capillary leak syndrome:an evidence-based review[J]. Expert Rev Cardiovasc Ther, 2018, 16(5):331-340.
[13] Bozzini MA, Milani GP, Bianchetti MG, et al. Idiopathic systemic capillary leak syndrome (Clarkson syndrome) in childhood:systematic literature review[J]. Eur J Pediatr, 2018, 177(8):1149-1154.
[14] Arnemann PH, Hessler M, Kampmeier T, et al. Resuscitation with hydroxyethyl starch maintains hemodynamic coherence in ovine hemorrhagic shock[J]. Anesthesiology, 2020, 132(1):131-139.
[15] Eo TS, Chun KJ, Hong SJ, et al. Clinical presentation, management, and prognostic factors of idiopathic systemic capillary leak syndrome:a systematic review[J]. J Allergy Clin Immunol Pract, 2018, 6(2):609-618.
[16] Druey KM, Parikh SM. Idiopathic systemic capillary leak syndrome (Clarkson disease)[J]. J Allergy Clin Immunol, 2017, 140(3):663-670.
[17] Marceau F, Bachelard H, Rivard GÉ, et al. Increased fibrinolysis-induced bradykinin formation in hereditary angioedema confirmed using stored plasma and biotechnological inhibitors[J]. BMC Res Notes, 2019, 12(1):291.
[18] Kulihova K, Prochazkova M, Semberova J, et al. Fatal primary capillary leak syndrome in a late preterm newborn[J]. Indian J Pediatr, 2016, 83(10):1197-1199.
[19] Carcillo JA. Intravenous fluid choices in critically ill children[J]. Curr Opin Crit Care, 2014, 20(4):396-401.
[20] Caironi P, Tognoni G, Masson S, et al. Albumin replacement in patients with severe sepsis or septic shock[J]. N Engl J Med, 2014, 370(15):1412-1421.
[21] Pineton de Chambrun M, Gousseff M, Mauhin W, et al. Intravenous immunoglobulins improve survival in monoclonal gammopathy-associated systemic capillary-leak syndrome[J]. Am J Med, 2017, 130(10):1219.e19-1219.e27.
[22] Xu Q, Yan Q, Chen S. Use of ulinastatin was associated with reduced mortality in critically ill patients with sepsis[J]. J Thorac Dis, 2019, 11(5):1911-1918.
